Evidence map›Paper›PMID 30803025›Full record

GuidelineJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2019

Diagnosis and Management of Paget's Disease of Bone in Adults: A Clinical Guideline.

Stuart H Ralston, Luis Corral-Gudino, Cyrus Cooper, Roger M Francis, William D Fraser, Luigi Gennari, Núria Guañabens, M Kassim Javaid, Robert Layfield, Terence W O'Neill and 7 more

Open access · hybridAbstract readPractice Guideline
In one paragraph

Guideline in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 107 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
107citing papers in PubMed, 2 pooled it
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

107 citing papers in PubMed, 2 syntheses or guidelines pooled it, 206 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. A hip that breaks the scale.EULAR rheumatology open · 2026
    Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

47 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 15 institutions in 5 countries.

Stuart H RalstonCentre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
Luis Corral-GudinoInternal Medicine Department, Hospital Universitario Río Hortega, University of Valladolid, Valladolid, Spain.
Cyrus CooperMRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK.
Roger M FrancisPaget's Association, Manchester, UK.
William D FraserNorwich Medical School, Faculty of Medicine and Health Sciences, University of East Anglia, Norwich, UK.
Luigi GennariDepartment of Medicine, Surgery, and Neurosciences, University of Siena, Siena, Italy.
Núria GuañabensHospital Clinic, IDIBAPS, CiberEHD, University of Barcelona, Barcelona, Spain.
M Kassim JavaidBotnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences, University of Oxford, Oxford, UK.
Robert LayfieldSchool of Life Sciences, University of Nottingham Medical School, Queen's Medical Centre, Nottingham, UK.
Terence W O'NeillArthritis Research UK Centre for Epidemiology, University of Manchester, Manchester, UK.
R Graham G RussellBotnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences, University of Oxford, Oxford, UK.
Michael D StoneBone Research Unit, University Hospital Llandough, Penarth, UK.
Keith SimpsonBotnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences, University of Oxford, Oxford, UK.
Diana WilkinsonBotnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences, University of Oxford, Oxford, UK.
Ruth WillsInternational Medical Press, London, UK.
M Carola ZillikensDepartment of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
Stephen P TuckDepartment of Rheumatology, The James Cook University Hospital, Middlesbrough, UK.
Nuffield Orthopaedic Centre · GBUniversity of Oxford · GBDSM (Netherlands) · NLHospital Clínic de Barcelona · ESInternational Medical Corps · USManchester University NHS Foundation Trust · GBMRC Institute of Genetics and Molecular Medicine · GBNewcastle University · GBPress Association · GBUniversidad de Valladolid · ESUniversity Hospital Llandough · GBUniversity of East Anglia · GBUniversity of Nottingham · GBUniversity of Siena · ITUniversity of Southampton · GB

Funding

European Calcified Tissues SocietyInternational Osteoporosis FoundationMedical Research Council G0400491Medical Research Council G0701603Medical Research Council G0801462Medical Research Council MC_U147585819Medical Research Council MC_U147585824Medical Research Council MC_U147585827Medical Research Council MC_UP_A620_1014Medical Research Council MC_UP_A620_1015Medical Research Council MC_UU_12011/1Medical Research Council MC_UU_12011/2Paget's AssociationVersus Arthritis 17702
6 · The paper itself

Abstract

An evidence-based clinical guideline for the diagnosis and management of Paget's disease of bone (PDB) was developed using GRADE methodology, by a Guideline Development Group (GDG) led by the Paget's Association (UK). A systematic review of diagnostic tests and pharmacological and nonpharmacological treatment options was conducted that sought to address several key questions of clinical relevance. Twelve recommendations and five conditional recommendations were made, but there was insufficient evidence to address eight of the questions posed. The following recommendations were identified as the most important: 1) Radionuclide bone scans, in addition to targeted radiographs, are recommended as a means of fully and accurately defining the extent of metabolically active disease in patients with PDB. 2) Serum total alkaline phosphatase (ALP) is recommended as a first-line biochemical screening test in combination with liver function tests in screening for the presence of metabolically active PDB. 3) Bisphosphonates are recommended for the treatment of bone pain associated with PDB. Zoledronic acid is recommended as the bisphosphonate most likely to give a favorable pain response. 4) Treatment aimed at improving symptoms is recommended over a treat-to-target strategy aimed at normalizing total ALP in PDB. 5) Total hip or knee replacements are recommended for patients with PDB who develop osteoarthritis in whom medical treatment is inadequate. There is insufficient information to recommend one type of surgical approach over another. The guideline was endorsed by the European Calcified Tissues Society, the International Osteoporosis Foundation, the American Society of Bone and Mineral Research, the Bone Research Society (UK), and the British Geriatric Society. The GDG noted that there had been a lack of research on patient-focused clinical outcomes in PDB and identified several areas where further research was needed. © 2019 The Authors. Journal of Bone and Mineral Research Published by Wiley Periodicals Inc.

Indexed as

Alkaline PhosphataseOsteitis DeformansZoledronic AcidAdultBiomarkersHumansSystematic Reviews as TopicAlkaline PhosphataseBiomarkersZoledronic AcidALPANTIRESORPTIVESBISPHOSPHONATESPAGET'S DISEASE OF BONERADIONUCLIDE BONE SCANS

Identifiers

PMID30803025
PMCPMC6522384
OpenAlexW2907719236

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.